home / stock / avir / avir short
Short Information | Atea Pharmaceuticals Inc. (NASDAQ:AVIR)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 658,630 |
Total Actual Volume | 6,113,640 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 32,932 |
Average Short Percentage | 12.29% |
Is there a AVIR Short Squeeze or Breakout about to happen?
See the AVIR Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-03-2024 | $3.22 | $3.28 | $3.35 | $3.21 | 165,365 | 15,635 | 9.45% |
07-02-2024 | $3.37 | $3.23 | $3.37 | $3.22 | 227,171 | 16,843 | 7.41% |
07-01-2024 | $3.29 | $3.37 | $3.4 | $3.205 | 253,987 | 25,911 | 10.2% |
06-28-2024 | $3.41 | $3.31 | $3.41 | $3.245 | 693,550 | 20,915 | 3.02% |
06-27-2024 | $3.37 | $3.38 | $3.42 | $3.35 | 165,910 | 11,576 | 6.98% |
06-26-2024 | $3.41 | $3.37 | $3.49 | $3.34 | 264,525 | 31,339 | 11.85% |
06-25-2024 | $3.46 | $3.43 | $3.59 | $3.41 | 210,571 | 40,659 | 19.31% |
06-24-2024 | $3.44 | $3.49 | $3.555 | $3.41 | 200,414 | 31,299 | 15.62% |
06-21-2024 | $3.43 | $3.44 | $3.61 | $3.36 | 641,153 | 41,601 | 6.49% |
06-20-2024 | $3.46 | $3.42 | $3.58 | $3.4 | 231,889 | 35,592 | 15.35% |
06-18-2024 | $3.52 | $3.49 | $3.65 | $3.49 | 227,132 | 50,111 | 22.06% |
06-17-2024 | $3.6 | $3.53 | $3.65 | $3.515 | 387,103 | 36,052 | 9.31% |
06-14-2024 | $3.7 | $3.61 | $3.74 | $3.58 | 264,277 | 39,294 | 14.87% |
06-13-2024 | $3.78 | $3.7 | $3.85 | $3.69 | 233,693 | 58,121 | 24.87% |
06-12-2024 | $3.92 | $3.78 | $3.97 | $3.78 | 283,351 | 57,302 | 20.22% |
06-11-2024 | $3.76 | $3.92 | $3.92 | $3.69 | 223,058 | 29,242 | 13.11% |
06-10-2024 | $3.68 | $3.79 | $3.94 | $3.645 | 754,470 | 53,045 | 7.03% |
06-07-2024 | $3.75 | $3.7 | $3.85 | $3.695 | 162,231 | 16,319 | 10.06% |
06-06-2024 | $3.93 | $3.8 | $3.95 | $3.799 | 221,140 | 22,817 | 10.32% |
06-05-2024 | $3.8 | $3.96 | $4.005 | $3.8 | 302,650 | 24,957 | 8.25% |
News, Short Squeeze, Breakout and More Instantly...
Atea Pharmaceuticals Inc. Company Name:
AVIR Stock Symbol:
NASDAQ Market:
Atea Pharmaceuticals Inc. Website:
97% SVR12 Rate Observed with 8 Weeks of Treatment in Lead-In Cohort of HCV-Infected Patients in Ongoing Phase 2 Clinical Study EASL Presentations Continue to Support Best-in-Class Potential with High Antiviral Potency, Short Treatment Duration, Low Risk of Drug Interaction and High Barr...
Presentations to Include New Antiviral Efficacy Results, Including SVR12 Data, from Lead-In Cohort of Ongoing Phase 2 HCV Trial Data Also Highlight the High Prevalence of Pre-Existing NS5A Resistance-Associated Substitutions (RAS) Detected in HCV-infected Patients BOSTON, May 22, 20...
Full Enrollment Achieved in Global Phase 3 SUNRISE-3 Trial for Treatment of COVID-19 with Results Expected 2H’24 Global Phase 2 HCV Study On Track to Report Complete SVR12 Results 2H’24 Multiple Presentations Showcasing Preclinical and New Phase 2 Efficacy Data to ...